|
Schober, C; Gibbs, J F; Yin, M B et al. (1994) Cellular heterogeneity in DNA damage and growth inhibition induced by ICI D1694, thymidylate synthase inhibitor, using single cell assays. Biochem Pharmacol 48:997-1002
|
|
Toth, K; Vaughan, M M; Slocum, H K et al. (1994) New immunohistochemical ""sandwich"" staining method for mdr1 P-glycoprotein detection with JSB-1 monoclonal antibody in formalin-fixed, paraffin-embedded human tissues. Am J Pathol 144:227-36
|
|
van Laar, J A; Durrani, F A; Rustum, Y M (1993) Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26. Cancer Res 53:1560-4
|
|
Malmberg, M; Slocum, H K; Rustum, Y M (1993) Growth slow-down and growth arrest of human colon carcinoma cells HCT-8 in vitro after exposure to 5-fluoro-2'-deoxyuridine. Cell Prolif 26:291-303
|
|
Creaven, P J; Rustum, Y M; Petrelli, N J et al. (1993) Clinical studies of the modulation of Ftorafur. Adv Exp Med Biol 339:253-62;discussion 263
|
|
Raymakers, R A; Slocum, H K; Minderman, H et al. (1993) Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system. Exp Hematol 21:602-7
|
|
Manzuik, L V; Perevodchikova, N I; Gorbunova, V A et al. (1993) Initial clinical experience with oral ftorafur and oral 6R,S leucovorin in advanced colorectal carcinoma. Eur J Cancer 29A:1793-4
|
|
Zhang, Z G; Malmberg, M; Yin, M B et al. (1993) Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine. Biochem Pharmacol 45:1157-64
|
|
Petrelli, N J; Rodriguez-Bigas, M; Rustum, Y et al. (1993) Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma. Cancer 72:1543-6
|
|
Cowens, J W; Creaven, P J; Greco, W R et al. (1993) Initial clinical (phase I) trial of TLC D-99 (doxorubicin encapsulated in liposomes). Cancer Res 53:2796-802
|
Showing the most recent 10 out of 80 publications
